Plain-English translation of NCT02920554 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a smaller liver removal (wedge resection) works as well as a larger removal (bisegmentectomy) for treating gallbladder cancer. The study involves patients with stage 2 or 3 gallbladder cancer who need surgery. Doctors want to understand which approach gives patients the best chance of staying cancer-free long-term.
Surgeons currently remove different amounts of liver tissue when treating gallbladder cancer, but it's unclear whether removing more tissue is always better. This trial aims to find the most effective approach that balances cancer control with patient recovery.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would undergo surgery with additional lymph node removal, and your surgeon would randomly assign you to receive either a smaller wedge resection or a larger bisegmentectomy of your liver. After surgery, your medical team would follow you over time to monitor whether your cancer returns and track your overall survival, comparing outcomes between the two surgical approaches.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
South Korea